NCT05691972 is a NA clinical trial of Restylane Contour in Temporal Hollowing, sponsored by Galderma R&D.

Who is sponsoring NCT05691972?

NCT05691972 is sponsored by Galderma R&D.

What drugs are being tested in NCT05691972?

Interventions in NCT05691972: Restylane Contour.

What condition does NCT05691972 study?

NCT05691972 studies Temporal Hollowing.

Is NCT05691972 still recruiting?

NCT05691972 is currently completed. Last updated 17 February 2025.

Last reviewed 2025-02-17 · How we verify

NCT05691972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

Completed NA Last updated 17 February 2025

What this trial tests

NA trial testing Restylane Contour in Temporal Hollowing in 225 participants. Completed in 11 December 2024.

Timeline

14 March 2023

Primary endpoint
26 October 2023

11 December 2024

Quick facts

Lead sponsor	Galderma R&D
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	225
Start date	14 March 2023
Primary completion	26 October 2023
Estimated completion	11 December 2024
Sites	15 locations across United States

Drugs / interventions tested

Restylane Contour

Conditions studied

Temporal Hollowing — all drugs for Temporal Hollowing →

Sponsor

Galderma R&D — full company profile →

Who can join

22 and older, any sex, with Temporal Hollowing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Restylane Contour

Trials testing the same drug.

NCT05622851 — Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers · NA · completed

Other Galderma R&D trials

Trials by the same sponsor.

NCT07047690 — A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis · Phase 2 · recruiting
NCT07344584 — A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles · NA · not yet recruiting
NCT07186413 — A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne · Phase 3 · recruiting
NCT07398989 — A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin · Phase 4 · completed
NCT06988618 — Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05691972 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Galderma R&D
Last refreshed: 17 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05691972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing